In the search for specific inhibitors of human 11β-hydroxysteroid- dehydrogenases (11β-HSDs): Chenodeoxycholic acid selectively inhibits 11β- HSD-I

European Journal of Endocrinology

Volumn 142, Issue 2, 2000, Pages 200-207

  Diederich, S ^a   Grossmann, C ^a   Hanke, B ^a   Quinkler, M ^a   Herrmann, M ^b   Bahr V ^a   Oelkers, W ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CARBENOXOLONE; CHENODEOXYCHOLIC ACID; DEOXYCORTICOSTERONE; DEXAMETHASONE DERIVATIVE; ENZYME INHIBITOR; GLYCYRRHETINIC ACID; KETOCONAZOLE; LITHOCHOLIC ACID; METYRAPONE; PROGESTERONE DERIVATIVE;

ARTICLE; DIABETES MELLITUS; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SUBSTRATE; GLUCONEOGENESIS; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; KIDNEY MICROSOME; LIVER MICROSOME; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0034056308     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1420200     Document Type: Article

References (42)

1. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA Sutanto WS et al. Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 1988 2 986-989.
2. Funder JW, Pearce PT, Smith R & Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988 242 583-585.
3. Tannin GM, Agarwal AK, Monder C, New MI & White PC. The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. Journal of Biological Chemistry 1991 266 16653-16658.
4. Albiston AL, Obeyesekere VR, Smith RE & Krozowski ZS. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Molecular and Cellular Endocrinology 1994 105 R11-R17.
5. Stewart PM. 11β-Hydroxysteroid dehydrogenase: Implications for clinical medicine. Clinical Endocrinology 1996 44 493-499.
6. Hirasawa G, Sasano H, Takahashi KI, Fukushima K, Suzuki T, Hiwatashi N et al. Colocalization of 11β-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human epithelia. Journal of Clinical Endocrinology and Metabolism 1997 82 3859-3863.
7. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987 237 268-275.
8. Oelkers W, Buchen S, Diederich S, Krain J, Muhme S & Schöneshöfer M. Impaired renal 11 beta-oxidation of 9 alpha-fluorocortisol: an explanation for its mineralocorticoid potency. Journal of Clinical Endocrinology and Metabolism 1994 78 928-932.
9. Diederich S, Hanke B, Bähr V & Oelkers W The metabolism of 9α-fluorinated steroids in the human kidney. Endocrine Research 1996 22 803-810.
10. Diederich S, Hanke B, Oelkers W & Bähr V. Metabolism of dexamethasone in the human kidney: Nicotinamide adenine dinucleotide-dependent 11β-reduction. Journal of Clinical Endocrinology and Metabolism 1997 82 1598-1602.
11. Li KXZ, Obeyesekere VR, Krozowski ZS & Ferrari P. Oxoreductase and dehydrogenase activities of the human and rat 11β-hydroxysteroid dehydrogenase type 2 enzyme. Endocrinology 1997 138 2948-2952.
12. Ballard PL, Carter JP, Graham BS & Baxter JD. A radioreceptor assay for evaluation of the plasma glucocorticoid activity of natural and synthetic steroids in man. Journal of Clinical Endocrinology and Metabolism 1975 41 290-304.
13. Whorwood CB, Mason JI, Ricketts ML, Howie AJ & Stewart PM. Detection of human 11β-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts. Molecular and Cellular Endocrinology 1995 110 R7-R12.
14. Whorwood CB, Franklyn JA, Sheppard MC & Stewart PM. Tissue localization of 11 beta-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor. Journal of Steroid Biochemistry and Molecular Biology 1992 41 21-28.
15. Lakshmi V & Monder C. Purification and characterization of the corticosteroid 11-beta-dehydrogenase component of the rat liver 11-beta-hydroxysteroid dehydrogenase complex. Endocrinology 1988 123 2390-2398.
16. Low SC, Chapman KE, Edwards CR & Seckl JR. 'Liver-type' 11 beta-hydroxysteroid dehydrogenase cDNA encodes reductase but not dehydrogenase activity in intact mammalian COS-7 cells. Journal of Molecular Endocrinology 1994 13 167-174.
17. Duperrex H, Kenouch S, Gaeggeler HP, Seckl JR, Edwards CR, Farman N et al. Rat liver 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid encodes oxoreductase activity in a mineralocorticoid-responsive toad bladder cell line. Endocrinology 132 1993 612-619.
18. Voice MW, Seckl JR, Edwards CRW & Chapman KE. 11β-Hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: A model system for the study of hepatic glucocorticoid metabolism. Biochemical Journal 1996 317 621-625.
19. Jamieson PM, Chapman KE, Edwards CRW & Seckl JR. 11β-hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: Effect of physiochemical and hormonal manipulations. Endocrinology 1995 136 4754-4761.
20. Walker BR, Connacher AA, Lindsay RM, Webb DJ & Edwards CRW. Carbenoxolone increases hepatic insulin sensitivity in man: A novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. Journal of Clinical Endocrinology and Metabolism 1995 80 3155-3159.
21. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P et al. 11Beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proceedings of the National Academy of Sciences of the USA 1997 94 14924-14929.
22. Jamieson PM, Nyirenda MJ, Walker BR, Chapman KE & Seckl JR. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11β-hydroxysteroid dehydrogenase type 1. Journal of Endocrinology 1999 160 103-109.
23. Bujalska IJ, Kumar S & Stewart PM. Does central obesity reflect 'Cushing's disease of the omentum'? Lancet 1997 349 1210-1213.
24. Diederich S, Hanke B, Burkhardt P, Müller M, Schöneshöfer M, Bähr V et al. Metabolism of synthetic corticosteroids by 11β-hydroxysteroid-dehydrogenases in man. Steroids 1998 63 271-277.
25. Diederich S, Quinkler M, Miller K, Heilmann P, Schoeneshofer M & Oelkers W. Human kidney 11 Beta-hydroxysteroid dehydrogenase: Regulation by adrenocorticotropin? European Journal of Endocrinology 1996 134 301-307.
26. Raven PW, Checkley SA & Taylor NF. Extra-adrenal effects of metyrapone include inhibition of the 11-oxoreductase activity of 11β-hydroxysteroid dehydrogenase: A model for 11-HSD 1 deficiency. Clinical Endocrinology 1995 43 637-644.
27. Sampath-Kumar R, Yu M, Khalil MW & Yang K. Metyrapone is a competitive inhibitor of 11β-hydroxysteroid dehydrogenase type 1 reductase. Journal of Steroid Biochemistry and Molecular Biology 1997 62 195-199.
28. Monder C, Lakshmi V & Miroff Y. Kinetic studies on rat liver 11 beta-hydroxysteroid dehydrogenase. Biochimica et Biophysica Acta 1991 1115 23-29.
29. Stewart PM, Murry BA & Mason JI. Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type 1 isoform. Journal of Clinical Endocrinology and Metabolism 1994 79 480-484.
30. Best R, Nelson SM & Walker BR. Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11β-hydroxysteroid dehydrogenase in vitro and in vivo. Journal of Endocrinology 1997 153 41-48.
31. Ferrari P, Smith RE, Funder JW & Krozowski ZS. Substrate and inhibitor specificity of the cloned human 11β-hydroxysteroid dehydrogenase type 2 isoform. American Journal of Physiology 1996 270 E900-E904.
32. Stewart PM, Wallace AM, Atherden SM, Shearing CH & Edwards CR. Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man. Clinical Science 1990 78 49-54.
33. Bujalska O, Shimojo M, Howie A & Stewart PM. Human 11β-hydroxysteroid dehydrogenase: Studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue. Steroids 1997 62 77-82.
34. Morita H, Zhou MY, Foecking MR Gomez-Sanchez EP, Cozza EN & Gomez-Sanchez CE. 11β-Hydroxysteroid dehydrogenase type 2 complementary daoxyribonucleic acid stably transfected into Chinese hamster ovary cells: Specilic inhibition by 11α-hydroxyprogesterone. Endocrinology 1996 137 2308-2314.
35. Souness GW, Latif SA, Laurenzo JL & Morris DJ. 11α- and 11β-hydroxyprogesterone, potent inhibitors of 11β-hydroxysteroid dehydrogenase (isoforms 1 and 2). confer marked mineralocorticoid activity on corticosterone in the ADX rat. Endocrinology 1995 136 1809-1812.
36. Latif SA, Sheff MF, Ribeiro CE & Morris DJ. Selective inhibition of sheep kidney 11β-hydroxysteroid dehydrogenase isoform 2 activity by 5α-reduced (but not 5β) derivatives of adrenocorticosteroids. Steroids 1997 62 230-237.
37. Perschel FH, Buhler H & Hierholzer K. Bile acids and their amidates inhibit 11 beta-hydroxysteroid dehydrogenase obtained from rat kidney. Pflüger's Archiv 1991 418 538-543.
38. Buhler H, Perschel FH, Fitzner R & Hierholzer K. Endogenous inhibitors of 11 beta-OHSD: existence and possible significance. Steroids 1994 59 131-135.
39. Gomez-Sanchez EP, Cox D, Foecking M, Ganjam V & Gomez-Sanchez CE. 11β-hydroxysteroid dehydrogenases of the choriocarcinoma cell line JEG-3 and their inhibition by glycyrrhetinic acid and other natural substances. Steroids 1996 61 110-115.
40. Ponz de Leon M, Loria P, Carulli N, Murphy GM & Dowling RH. Intestinal solubilization, absorption, pharmacokinetics and bioavailabilily of chenodeoxycholic acid. European Journal of Clinical Investigation 1980 10 261-271.
41. Maser E & Oppermann UCT. The 11β-hydroxysteroid dehydrogenase system, a determinant of glucocorticoid and mineralocorticoid action - role of type-1 11β-hydroxysteroid dehydrogenase in detoxification processes. European Journal of Biochemistry 1997 249 365-369.
42. Ulrich B, Frey FJ, Speck RF & Frey BM. Pharmacokinetics/pharmacodynamics of ketoconazole-prednisolone interaction. Journal of Pharmacology and Experimental Therapeutics 1992 260 487-490.